等待时间决定了脆弱性的影响:西班牙多中心前性研究
Lorena Puchades1,2, Julia Herreras1, Ana Ibañez3
1Medical Research Institute Hospital La Fe, Hepatology and Liver Transplantation group, Valencia, Spain.
JHEP reports : innovation in hepatology
|September 28, 2023
概括
虚弱性不能预测肝移植候选人的移植前死亡率等待时间短. 然而,脆弱的患者经历了更长的住院时间和早期移植后并发症的增加.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 移植手术 移植手术
- 老年病的医生 老年病的医生
背景情况:
- 在肝移植候选人中,脆弱性很常见,并且与美国的不良结果有关.
- 关于北美以外的脆弱性影响的数据有限.
- 客观脆弱工具需要在不同的肝移植环境中进行验证.
研究的目的:
- 在欧洲多中心队列中对肝脏脆弱指数 (LFI) 进行外部验证.
- 评估移植前虚弱与移植前和移植后结果的关联.
主要方法:
- 从五个西班牙中心招募212名肝硬化门诊患者 (2018-2020年).
- 使用LFI ≥4.5.5的脆弱性的定义.
- 随访至少6个月,以评估死亡率,住院/ICU,并发症,再移植和心血管事件.
主要成果:
- 21%的患者 (n=45) 虚弱,LFI的中位数为3.9.
- 在调整年龄和MELD-Na.之后,脆弱性没有预测移植前死亡率或退出名单 (HR 1.48,p=0.586).
- 虚弱的患者住院时间更长 (13 vs. 9天,p=0.001) 和早期移植后并发症率更高 (100% vs. 55%,p=0.021).
结论:
- 在肝移植设置中,等待时间很短,脆弱性不会影响移植前死亡率.
- 移植前的脆弱性预测了移植后并发症率的增加和更长的住院时间.
- 需要进一步的研究来证实这些环境中预康复策略的好处.
相关概念视频
Assumptions of Survival Analysis
153
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
153
The Effect of Aging on Tissues
2.1K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
2.1K
Heart Failure VII: Nursing Interventions
89
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
89
Factors Affecting Protein-Drug Binding: Patient-Related Factors
73
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
73


